...
首页> 外文期刊>Medical Physics >SU‐F‐J‐22: Lung VolumeVariability Assessed by Bh‐CBCT in 3D Surface Image Guided Deep InspirationBreath Hold (DIBH) Radiotherapy for Left‐Sided Breast Cancer
【24h】

SU‐F‐J‐22: Lung VolumeVariability Assessed by Bh‐CBCT in 3D Surface Image Guided Deep InspirationBreath Hold (DIBH) Radiotherapy for Left‐Sided Breast Cancer

机译:SU-F-J-22:BH-CBCT在3D表面图像中评估的肺容量,引导左侧乳腺癌的深度溶解(DIBH)放射治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: With the increasing use of DIBH techniques for left‐sided breast cancer, 3D surface‐image guided DIBH techniques have improved patient setup and facilitated DIBH radiation delivery. However, quantification of the daily separation between the heart and left breast still presents a challenge. One method of assuring separation is to ensure consistent left lung filling. With this in mind, the aim of this study is to retrospectively quantify left lung volume from weekly breath hold‐CBCTs (bh‐CBCT) of left‐sided breast patients treated using a 3D surface imaging system. Methods: Ten patients (n=10) previously treated to the left breast using the C‐Rad CatalystHD system (C‐RAD AG, Uppsala Sweden) were evaluated. Patients were positioned with CatalystHD and with bh‐CBCT. bh‐CBCTs were acquired at the validation date, first day of treatment and at subsequent weekly intervals. Total treatment courses spanned from 3 to 5 weeks. bh‐CBCT images were exported to VelocityAI and the left lung volume was segmented. Volumes were recorded and analyzed. Results: A total of 41 bh‐CBCTs were contoured in VelocityAI for the 10 patients. The mean left lung volume for all patients was 1657±295cc based on validation bh‐CBCT. With the subsequent lung volumes normalized to the validation lung volume, the mean relative ratios for all patients were 1.02±0.11, 0.97±0.14, 0.98±0.11, 1.02±0.01, and 0.96±0.02 for week 1, 2, 3, 4, and 5, respectively. Overall, the mean left lung volume change was ≤4.0% over a 5‐week course; however left lung volume variations of up to 28% were noted in a select patient. Conclusion: With the use of the C‐RAD CatalystHD system, the mean lung volume variability over a 5‐week course of DIBH treatments was ≤4.0%. By minimizing left lung volume variability, heart to left breast separation maybe more consistently maintained. AN Gutierrez has a research grant from C‐RAD AG.
机译:目的:随着DIBH技术的越来越多的左侧乳腺癌,3D表面图像引导的DIBH技术具有改进的患者设置和促进DIBH辐射递送。然而,在心脏和左乳房之间的日常分离量化仍然存在挑战。一种确保分离的一种方法是确保一致的左肺填充。考虑到这项研究,本研究的目的是回顾使用3D表面成像系统治疗的左侧乳房患者的每周呼吸HOLD-CBCT(BH-CBCT)来定量左肺体积。方法:使用C-RAD催化剂系统(C-RAD AG,Qupsala瑞典)评价前面将10名患者(n = 10)治疗到左乳房。患者用催化剂和BH-CBCT定位。 BH-CBCT在验证日期,治疗第一天和随后的每周间隔收购。总处理课程从3到5周禁止。 BH-CBCT图像出口到Velocityai,左肺体积分段。记录和分析卷。结果:10名患者的Velocityai共有41个BH-CBCT。所有患者的平均左肺体积为1657±295cc,基于验证BH-CBCT。随着随后的肺部量归一批肺部量,所有患者的平均相对比为1.02±0.11,0.97±0.14,0.98±0.11,1.02±0.01,0.96±0.02,为每周1,2,3,4,和5分别。总体而言,在5周的课程中,平均左肺体积变化≤4.0%;然而,在选择的患者中,注意到左肺体积变化高达28%。结论:通过使用C-RAD催化剂系统,在5周的DIBH治疗过程中平均肺部变异性≤4.0%。通过最小化左肺体积变异性,可以更加持续保持乳房分离。 Gutierrez拥有C-RAD AG的研究授权。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号